Record revenue of €209 million in first quarter reflecting 15% topline growth
11 April 2024 - 3:00PM
Record revenue of €209 million in first quarter reflecting 15%
topline growth
Regulated information - inside informationNazareth
(Belgium)/Rotterdam (The Netherlands), 11 April 2024 – 7:00 AM
CET
Record revenue of €209 million in first quarter
reflecting 15% topline growth
Fagron, the leading global player in pharmaceutical compounding
today publishes its quarterly results for the period ending 31
March 2024.
Key Highlights
- Revenue growth accelerated to
15.3% reported growth (14.9% at CER) resulting in €209.2 million,
supported by all regions
- Organic growth at CER of 12.3%
reflects the continued strong performance in North America and
robustness in EMEA
- Global operational excellence
initiatives on track and yielding efficiencies
- Integration of LSP and Parma
Produkt progressing as planned; remain committed to disciplined
acquisition strategy
- FY 2024 outlook of high
single-digit organic sales growth and improvement in profitability
reaffirmed
Rafael Padilla, CEO of Fagron:
“I am pleased to
report another excellent quarter for Fagron with our teams
delivering commendable results. The market dynamics across our
regions are challenging, yet Fagron’s business model proves
resilient, affirming our unique global positioning and
leadership.
Our organic growth is driven by our focused commercial strategy,
operational efficiencies, and the successful implementation of our
global excellence initiatives. North America in particular has seen
record growth with strong underlying demand at both FSS and Anazao.
In EMEA, we have delivered a strong performance despite the impact
of the change in reimbursement policy in Poland, as other markets
compensated adequately, further highlighting the strength of our
diversification strategy. In Latin America, growth has slowed
slightly this quarter due to seasonal effects, while the
competitive and consumer dynamics remained unchanged.
We are on track with the integration of our recent acquisitions
and remain committed to exploring market opportunities globally to
further strengthen our position.
Overall, we are confident in our outlook and reiterate our FY
2024 and mid-term guidance, as we continue to capitalize on growth
opportunities that support our strategic objectives.”
Please open the link below for the full press release:
- Record revenue of €209 million in first quarter reflecting 15%
topline growth
Fagron NV (TG:4A5)
Historical Stock Chart
From Nov 2024 to Dec 2024
Fagron NV (TG:4A5)
Historical Stock Chart
From Dec 2023 to Dec 2024
